Progesterone receptor status and tumor grade predict the 21-gene recurrence score of invasive lobular breast cancer.

Conclusion: The 21-gene RS testing may not be necessary for patients with PR+/G1-2 ILC. PMID: 31234641 [PubMed - as supplied by publisher]
Source: Future Medicine: Biomarkers in Medicine - Category: Internal Medicine Tags: Biomark Med Source Type: research